1
Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
Condition(s):Metastatic Colorectal CancerLast Updated:March 20, 2023Recruiting
Cetuximab: 1059 Clinical Trials, Page 1 of 106
Hide Studies Not Open or Pending
2
The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment
Condition(s):Colorectal Cancer; Drug Resistance; Mass Spectrometry; RAS-RAF Pathway DeregulationLast Updated:January 17, 2018Unknown status
3
Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate
Condition(s):Head and Neck Squamous Cell Carcinoma; Margin AssessmentLast Updated:May 3, 2021Unknown status
4
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
Condition(s):Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Squamous Cell Carcinoma; Metastatic Head-and-neck Squamous-cell CarcinomaLast Updated:September 8, 2023Recruiting
5
Cetuximab in Head and Neck Cancer Patients
Condition(s):Head and Neck Cancer; Squamous Cell CarcinomaLast Updated:May 24, 2023Completed
6
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
Condition(s):Metastatic Colorectal CancerLast Updated:August 31, 2023Recruiting
7
Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
Condition(s):Head and Neck Squamous Cell Carcinoma; Colorectal Cancer; Cutaneous Squamous Cell Carcinoma; Anal Squamous Cell Carcinoma; Cervical CancerLast Updated:May 16, 2023Completed
8
Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC
Condition(s):Colorectal Neoplasms MalignantLast Updated:September 13, 2022Recruiting
9
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
Condition(s):Microsatellite Stable Metastatic Colorectal CancerLast Updated:September 14, 2023Active, not recruiting
10
A Phase 1b Study of WU-NK-101 in Combination With Cetuximab
Condition(s):Colorectal Cancer Metastatic; Squamous Cell Carcinoma of Head and NeckLast Updated:July 6, 2023Not yet recruiting